MIT-led team receives funding to pursue new treatments for metabolic disease
Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.
Anne Trafton | MIT News •
mit
Feb. 5, 2024 • ~6 min
Feb. 5, 2024 • ~6 min
/
103